← All Investors
KINIKSA PHARMACEUTICALS INTL
KNSA
Holders
6
Combined Value
$121M
Combined Shares
2,520,271
Current Price
$54.21
52W High
$59.87
vs 52W High
−9.5%
Investor Activity
BUYSELLImplied priceClick a quarter to see who traded
Held By
| Investor | Value | % of Portfolio | Avg Buy Price | Gain | Last Activity | As of |
|---|---|---|---|---|---|---|
| Steve Cohen - Point72 | $30M | 0.04% | ~$27.71 | +95.6% | Sold Q1 2026 | Q1 2026 |
| Israel Englander - Millennium Management | $27M | 0.01% | ~$20.72 | +161.7% | Sold Q1 2026 | Q1 2026 |
| Ken Griffin - Citadel Advisors | $24M | 0.00% | ~$35.15 | +54.2% | Sold Q1 2026 | Q1 2026 |
| Ken Fisher - Fisher Investments | $20M | 0.01% | ~$38.45 | +41.0% | Bought Q1 2026 | Q1 2026 |
| Cliff Asness - AQR Capital | $18M | 0.01% | ~$24.44 | +121.8% | Bought Q1 2026 | Q1 2026 |
| Joel Greenblatt - Gotham Asset Management | $364K | 0.00% | ~$30.70 | +76.6% | Bought Q1 2026 | Q1 2026 |
Recent Activity
Ownership History
| Period | Holders | Total Shares | Δ Shares | Total Value | Implied Price |
|---|---|---|---|---|---|
| Q1 2026 | 6 | 2,520,271 | −16.4% | $121M | $48.15 |
| Q4 2025 | 7 | 3,014,887 | +17.9% | $124M | $41.25 |
| Q3 2025 | 7 | 2,556,849 | −5.5% | $99M | $38.83 |
| Q2 2025 | 7 | 2,704,380 | −1.0% | $74M | $27.67 |
| Q1 2025 | 6 | 2,731,515 | +107.4% | $60M | $22.21 |
| Q4 2024 | 4 | 1,317,214 | +37.0% | $26M | $19.78 |
| Q3 2024 | 5 | 961,567 | +14.2% | $24M | $24.99 |
| Q2 2024 | 4 | 841,788 | — | $15M | $18.67 |